Immunizing Pharmacist Certification Program for Public Health Pharmacists 2022

The Department of Health-Pharmaceutical Division (DOH-PD) in collaboration with the Philippine Pharmacists Association (PPhA) conducted a face-to-face Immunizing Pharmacist Certification Program (IPCP) for Public Health Pharmacists (PHPs) with a theme of, “Empowering Public Health Pharmacists as Frontliner in the midst of pandemic through the delivery of quality health care system for the integration of Universal Health Care.”




To read the full article, kindly click the title.

Advisory for the Public Consultation on the Draft Administrative Order entitled “Revised Implementing Guidelines on the Electronic Drug Price Monitoring System”

Republic Act No. 9502, otherwise known as the “Universally Accessible Cheaper and Quality Medicines Act of 2008,” mandated the Secretary of Health (SOH)to establish and initiate an electronic price monitoring and regulation system for drugs and medicines which is now known as the Electronic Drug Price Monitoring System (EDPMS).

Click the title to read more about the advisory.

Philippine Antimicrobial Awareness Week 2022

The Department of Health (DOH), together with other member agencies of the Inter-Agency Committee on Antimicrobial Resistance (ICAMR), culminated the week-long celebration of the Philippine Antimicrobial Awareness Week (PAAW) highlighting the importance of the One Health approach to combat antimicrobial resistance (AMR) fuelled by the COVID-19 pandemic threat.

Philippine Essential medical Device List

The Philippine Essential Medical Device List (PEMDL) is a compilation of essential medical devices considered as important or necessary for the preventive, diagnostic, therapeutic, or rehabilitative procedures carried out in government health facilities in accordance with Administrative Order No. 2021-0038 “Framework for Philippine Essential Medical Devices List and Price Reference Index”.



Click the title to know more about the PEMDL

DOH updates list of VAT-Exempt Medicines under RA 11354

The Department of Health (DOH) informed the Bureau of Internal Revenue (BIR) through Commissioner Caesar R. Dulay the revisions to the list of VAT-Exempt Medicines under Republic Act. 11354 or Corporate Recovery and Tax Incentives for Enterprises (CREATE) Act.

Strategic Framework and Implementing Guidelines of the Philippine Medicines Policy 2022-2030

Pursuant to the Government’s thrust towards Universal Health Care (UHC) and in light of the major changes in the pharmaceutical landscape, the Department of Health (DOH), through the Pharmaceutical Division (PD), crafted the Philippine Medicines Policy which would be implemented from the years 2022 to 2030 to mobilize all key players in the pharmaceutical sector to implement evidence-based policies, improve sustainability programs and leverage best practices throughout the pharmaceutical supply chain.